Accepted for/Published in: JMIR Dermatology
Date Submitted: Feb 17, 2022
Date Accepted: May 13, 2022
Date Submitted to PubMed: Aug 26, 2023
Experience of 3D total-body photography to monitor naevi: Results from an Australian general population-based cohort study
ABSTRACT
Background:
Digital three-dimensional (3D) total-body photography of the skin surface is an emerging imaging modality that can facilitate the identification of new and changing naevi.
Objective:
We aimed to describe the experiences of study participants drawn from the general population who were provided 3D total-body photography and dermoscopy for the monitoring of naevi.
Methods:
A population-based, prospective study of adults aged 20-69 years from South-East Queensland, Australia was conducted. Participants underwent 3D total-body photography and dermoscopy every six months over a 3-year period. Participants were asked to provide closed and open-ended feedback on their 3D total-body photography and dermoscopy experience (such as comfort, trust, intended future use and willingness to pay) at the halfway study timepoint (18-months) and final study timepoint (36-months). We assessed changes in participants’ reported experience of 3D total-body photography and patient characteristics associated with patient experience at the end of the study (36-months) were analysed.
Results:
149 participants completed the surveys at both the 18- and 36-month timepoints (median age 55.0 (range 23-70); 63.1% (94/149) were male). At the 18-month timepoint, most participants (103/149, 69.1%) stated they completely trusted 3D total-body imaging for the diagnosis and monitoring of their naevi and this did not change at the 36-month (104/149, 69.8%) timepoint. The majority of participants reported they were very comfortable or comfortable with the technology at both the 18- and 36-month timepoints respectively (138/149, 92.6%; 140/149, 94.0%), albeit the number of participants reporting they were ‘very comfortable’ reduced significantly between the 18- and 36-month timepoints, from 71.1% to 61.1% (P=.012). Almost all participants (94%) would consider using this technology if it were to become commercially available, and this did not change during the two study timepoints. Half of participants (74/149) cited barriers to participating in 3D total-body photography, including trust in the ability of this technology to detect and monitor suspicious lesions, digital privacy, cost, and travel requirements.
Conclusions:
The majority of participants expressed positive attitudes towards 3D total-body photography for the monitoring of their moles. Half the participants identified potential barriers to uptake.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.